Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tabuk Pharmaceuticals Manufacturing Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7559
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group, is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products. The company offers products in various therapeutic areas including alimentary tract and metabolism, antineoplastic and immuno-modulators, blood and blood forming organs, cardiovascular system, systemic anti infective, dermatologicals, genito-urinary system and sex hormones, multivitamin, musculo skeletal, nervous system, parasitology and respiratory system, among others. It markets its products in Saudi Arabia and abroad. Tabuk is headquartered in Riyadh, Saudi Arabia.

Tabuk Pharmaceuticals Manufacturing Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Licensing Agreements 12
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Asset Transactions 17
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company – Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Key Facts 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Deals By Therapy Area, 2012 to YTD 2018 8
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tabuk Pharma Enters into Distribution Agreement with Renapharma 10
Tabuk Pharma Enters into Distribution Agreement with Genetic 11
Tabuk Pharma Enters into Licensing Agreement with Selectchemie 12
Tabuk Pharma Enters into Licensing Agreement with Dong-A ST for Zydena 13
Innovus Pharma Enters into Licensing Agreement with Tabuk Pharma 14
Tabuk Pharma Enters into Licensing Agreement with Aenova 15
Tabuk Pharma Enters into Licensing Agreement with Pfizer 16
Acino Pharma Acquires Three Products from Tabuk Pharma 17
Tabuk Pharmaceuticals Manufacturing Company, Key Competitors 18
Tabuk Pharmaceuticals Manufacturing Company, Other Locations 18

List of Figures
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tabuk Pharmaceuticals Manufacturing Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SmartCool Systems Inc (SSC):電力:M&Aディール及び事業提携情報
    Summary SmartCool Systems Inc (SmartCool Systems) is a clean technology company that manufactures and sells energy and cost reduction technologies. The company’s products include ECO3, ESM, and soft solutions. Its ECO3 and ESM are retrofit technologies that reduce the energy consumption of compresso …
  • Bell Helicopter Textron Inc.:企業の戦略・SWOT・財務情報
    Bell Helicopter Textron Inc. - Strategy, SWOT and Corporate Finance Report Summary Bell Helicopter Textron Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Reno de Medici S.p.A.:企業の戦略・SWOT・財務情報
    Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Netmedia S.A.
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Yes Bank Ltd:企業のM&A・事業提携・投資動向
    Yes Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yes Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Invectys SA-製薬・医療分野:企業M&A・提携分析
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company’s product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal a …
  • Western Farmers Electric Cooperative:企業の発電所・SWOT分析2018
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • ITV plc:企業の戦略・SWOT・財務情報
    ITV plc - Strategy, SWOT and Corporate Finance Report Summary ITV plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Tesla Inc (TSLA):電力:M&Aディール及び事業提携情報
    Summary Tesla Inc (Tesla), formerly Tesla Motors, Inc., is an automotive and vertically integrated sustainable energy company. It designs, develops, manufactures and sells electric vehicles and energy storage products. The company also installs and maintains electric vehicles and energy storage syst …
  • Marquette Capital Partners LLC:企業の戦略・SWOT・財務情報
    Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report Summary Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Titanium Metals Corp:企業の戦略・SWOT・財務分析
    Titanium Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Titanium Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sermonix Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company’s lead product include lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting women that …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆